- Filed
- Apr 23, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 11, 2025 | 28.98M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $283.91M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $86.6M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $118.66M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $61.32M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $46.05M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $28.17M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $331.18M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $319.26M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $339.22M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $308.57M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $326.4M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $479.83M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $489.08M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $283.49M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 31.43M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $6.2M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $60.14M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $85.92M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $34.13M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.10 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.22 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $13.37M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $22.52M |
| Net Income | Q1 2025 · Mar 31, 2024 | $33.34M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$11.73M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $37.55M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $39.28M |
| Revenue | Q1 2025 · Mar 31, 2024 | $76.83M |